In a murine model of hepatocellular carcinoma, treatment with CXCR2-modified CAR T cells significantly reduced tumor burden and enhanced intra-tumoral T-cell infiltration [65]. The gene discussed is CXCR2; the disease is hepatocellular carcinoma.